Tenet Reports Results for the Third Quarter Ended September 30, 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Tenet Healthcare (THC) Tops Q3 EPS by 23c; Lower Outlook
November 6, 2017 4:23 PM ESTTenet Healthcare (NYSE: THC) reported Q3 EPS of ($0.17), $0.23 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $4.59 billion versus the consensus estimate of $4.68 billion.
GUIDANCE:
Tenet Healthcare sees FY2017 EPS of $0.59-$0.74, versus the consensus of $0.76.
Reported a net loss from continuing operations attributable to Tenet shareholders of $366 million or $3.63 per diluted share. Adjusted diluted loss per share from continuing operations was $0.17.Adjusted EBITDA was $507 million... More